Democritus University of Thrace (DUTH)
Μοριακή μελέτη τελομερών και τελομεράσης στα μυελοϋπερπλαστικά σύνδρομα
Abstract
dc:descriptionRecent published data demonstrate that dynamics of telomere length and telomerase activity is involved in the molecular pathogenesis of many hematological malignancies. Furthermore, the presence of eroded telomeres and enhanced telomerase activity in hematopoietic cells is associated with poor prognosis in these malignancies. Ph1-negative Chronic Myeloproliferative Disorders (Ph- - CMPD) are acquired diseases of the hematopoietic stem cell, which are characterized by clonal proliferation of one or more cell lineages and they are connected with a variable risk of thrombohemorrhagic complications and predisposition to transformation into acute leukemia. The aim of the present study was to evaluate telomere length and telomerase activity in Ph- - CMPD patients either at diagnosis or during the course of the disease and to assess their clinical utility. Sixty-six bone marrow and 60 peripheral blood samples were obtained from 80 Ph- - CMPD patients with median age 62 years (range 17-84 years) and 18 healthy age-matched controls with median age 57 years (range 28-75 years). Thirty-six patients had Polycythemia Vera, 36 had Essential Thombocythemia, 4 had Idiopathic Myelofibrosis and 4 had Unclassified CMPD. Twenty-six samples were studied at diagnosis, whereas 54 during the course of the disease. Telomere length analysis of individual chromosome ends was performed on bone marrow metaphases using Quantitative Fluorescence In Situ Hybridization (Quantitative- F.I.S.H.). Telomerase activity was determined in bone marrow CD34(+) and CD20(+) cells as well as in peripheral blood CD3(+) T-lymphocytes and granulocytes with TRAP assay. Gene expression of telomerase-associated proteins was assayed by Real-Time Multiplex PCR. Ph- - CMPD patients showed significantly more eroded telomeres (p=0.010) and increased telomerase activity in CD34(+) cells (p=0.005) compared to healthy age-matched individuals. However, there was no statistical difference in telomere length (p=0.451) and enzyme activity (p=0.538) among different groups of Ph- - CMPD. Telomerase activity was not detected in the remaining hematopoietic cells both in patients and healthy controls, which was closely correlated with downregulation in hTERT mRNA expression. Chromosomal aberrations (del2012, del13q14, +8, +9) were found by F.I.S.H. in 37% Ph- - CMPD patients with reduced telomere lengths (p=0.001) and enhanced telomerase activity (p=0.014), especially during the course of the disease (p=0.028). The patients with shortened telomeres displayed a higher incidence of having thrombotic or hemorrhagic events during follow-up (p=0.011), treatment failure (p=0.024) and disease progression to myelofibrosis, myelodysplastic syndromes, secondary leukemia or death (p=0.137). Nevertheless, telomerase expression was not correlated with the above complications. The event free survival (survival without complications, e.g. myelofibrosis, myelodysplastic syndromes, secondary leukemia and death) was significantly shorter in patients with remarkable telomere erosion (Log Rank p=0.033), who demonstrated a 7,71-fold higher probability of having complications within five years from the initial diagnosis (95% CI=2,04-31,49 p<0.001). In conclusion, accelerated telomere shortening due to rapid cell division may not be prevented or restored by telomerase activity in most of the Ph- - CMPD myeloid cells. This loss of telomere stability seems to induce further genetic changes such as chromosomal rearrangement and consequently a multistage neoplastic transformation of these disorders. Moreover, the negative correlation between telomere length and survival probability of Ph- - CMPD patients is indicative that telomere dynamics may serve as a useful prognostic factor for these patients.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bazdiara, Ioanna-Vasiliki
- Μπαζντιάρα, Ιωάννα-Βασιλική
Subjects
dc:subject × 20- Τελομερή
- Τελομεράση
- Μυελοϋπερπλαστικά σύνδρομα
- Ανάστροφη μεταγραφάση hTERT
- RNA υπομονάδα hTR
- Αιμοποιητικά κύτταρα
- Ποσοτική φθορίζουσα in situ υβριδοποίηση (Q-F.I.S.H.)
- Υεχνική ενίσχυσης του τελομεριδιακού DNA (TRAP)
- Telomeres
- Telomerase
- Myeloproliferative disorders
- Reverse transcriptase hTERT
- RNA subunit hTR
- Haematopoietic cells
- Quantitative fluorescence in situ hybridization (Q-F.I.S.H.)
- Telomeric repeat amplification protocol (TRAP)
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21070